If you're pursuing a treatment compound or device for respiratory and lung diseases such as asthma, chronic obstructive pulmonary disease (COPD), lung cancers, cystic fibrosis (CF) or idiopathic pulmonary fibrosis we can give you access to preclinical pharmacological PD models, an extensive inhalation team and facility and medical device development as well as clinical trials and post-market reimbursement strategies.

Respiratory and lung disease development, including inhalation administration routes, from preclinical to post-market


新しい吸入薬の発展
吸入薬に新しい息吹を吹き込む
吸引薬の市場は急成長を遂げており、呼吸器疾患の治療のための 100 以上の製薬化合物が、現在開発途上にあります。当社ではこの急成長に対応すべく、1000 万ドル規模の拡張を進めています。当社の吸入薬への投資について詳細をご覧ください。
お問い合わせはこちら
お問い合わせ